Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05754944 · ClinicalTrials.gov registry record
Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery
A clinical trial of Peripheral Arterial Disease (PAD) in Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 114
- Enrollment target
- 1
- Study location
NCT05754944: Active study of Peripheral Arterial Disease (PAD) in Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05754944 is a study of Peripheral Arterial Disease (PAD) in Cancer Patients that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 114 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05754944, a study of Peripheral Arterial Disease (PAD) in Cancer Patients, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are studying whether people with risk factors for blood circulation disease have a condition called peripheral arterial disease (PAD). People with PAD have poor blood circulation because of narrowing or blocks in blood vessels caused by fat or calcium deposits (atherosclerosis). The study researchers think that PAD may lead to worse outcomes in cancer treatment, but people with cancer are not routinely tested for the disease. The purpose of this study is to find out how common PAD is among people with cancer who have risk factors for blood circulation disease, and to compare how often PAD is diagnosed in different racial groups
Primary Outcome
Completion of ABI/TBI to be able to assess prevalence of PAD
Conditions Studied
Interventions
- OTHER Questionnaires
- DIAGNOSTIC_TEST ABI/TBI
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2027-02 |
What the registry record for NCT05754944 still lists
NCT05754944 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Peripheral Arterial Disease (PAD) in Cancer Patients appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT05754944 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05754944 about?
NCT05754944 is a clinical study titled "Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery". Researchers are studying whether people with risk factors for blood circulation disease have a condition called peripheral arterial disease (PAD). People with PAD have poor blood circulation because of narrowing or blocks in blood vessels caused by fat or calcium deposits (atherosclerosis). The stud...
What is the current status of trial NCT05754944?
This trial is currently active not recruiting. The enrollment target is 114 participants. The study started on 2023-02-22. Estimated completion is 2027-02.
What conditions does trial NCT05754944 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease (PAD) in Cancer Patients.
What interventions are being tested in trial NCT05754944?
The interventions under investigation include: Questionnaires (OTHER), ABI/TBI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05754944?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05754944 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI